Lilly expands manufacturing footprint in Ireland with $1.8 billion investment
Lilly makes major investment in Ireland and commits to advancing new medical discoveries.
Eli Lilly and Company announced a $1 billion expansion of its Limerick, Ireland, manufacturing site to increase production of biologic active ingredients, including those for its Alzheimer’s treatment. Additionally, Lilly unveiled an $800 million expansion in Kinsale, Ireland, to meet demand for diabetes and obesity treatments. Since 2020, Lilly has invested over $20 billion in manufacturing expansions in the U.S. and Europe.
Lilly is designing the new manufacturing facilities with its 2030 Environmental Goals in mind. Once the Limerick site is complete, it will operate with 35% lower energy intensity, use 40% less water and generate 15% less waste than traditional biopharmaceutical manufacturing processes.
With this the company also highlights its commitment to addressing major health issues and advancing new medical discoveries.
Press release - Lilly invests an additional $1.8billion in Ireland (Sept 2024)
EU-CAR 2024-146
Tags in this Article:
No categories
Related articles
EPP says EU needs Alzheimer’s plan with concrete measures and deadlines
We understand the burden that Alzheimer’s disease (AD) places on individuals, caregivers and societies, and have dedicated more than 30 years to advancing the science of this devastating disease. We continue to encourage the recognition of initial cognitive changes caused by AD and the need to arm clinicians with resources to support early and accurate diagnosis, and for policymakers to provide investment in services and access to new therapeutics that strike at the potential causes of disease.
2023 Sustainability Report
Lilly unites caring with discovery to create medicines that make life better for people around the world. We strive to set measurable goals to track the progress and performance of our sustainability strategy. Our goals help drive accountability and are grounded in our purpose to create medicines that make life better.
Progress on Alzheimer’s Disease stagnating, warns Alzheimer Disease International CEO...
While stopping the progression of Alzheimer’s disease is not yet possible, hope is on the horizon in the form of new breakthroughs in diagnostics and new treatments. Yet scientific advances alone are not enough; public awareness, clinical practice and healthcare systems across the world must evolve in-step with scientific progress to drive confidence in what can now be achieved and deliver meaningful change for those affected.